| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $50.3M | +8.7% | +103.9% |
| SG&A Expense | $17.4M | +15.0% | +112.5% |
| Operating Income | -$67.7M | -10.2% | -106.0% |
| Pre-tax Income | -$62.2M | -12.7% | -134.9% |
| Income Tax | $102K | +96.2% | -10.5% |
| Net Income | -$62.3M | -12.8% | -134.3% |
| EPS (Basic) | -$1.77 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $140.7M | +10.5% | -27.0% |
| Short-term Investments | $475.3M | -9.1% | +61.3% |
| Current Assets | $627.2M | -5.2% | +27.2% |
| Total Assets | $630.5M | -5.2% | +27.3% |
| Current Liabilities | $26.7M | +29.8% | +5.0% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$137.1M | — | — |
| Capital Expenditures | $913K | — | — |
| Investing Cash Flow | -$171.4M | — | — |
| Financing Cash Flow | $256.7M | — | — |
| Free Cash Flow | -$138.0M | — | — |
| -12.0% |
| -98.9% |
| EPS (Diluted) | -$1.77 | -12.0% | -98.9% |
| $28.9M |
| +0.7% |
| — |
| Total Liabilities | $57.1M | +12.1% | +109.9% |
| Stockholders' Equity | $573.4M | -6.6% | +22.5% |